Skip to content

Median Effective Flow Rate of High-Flow Nasal Oxygen During Painless Gastroscopy With Sedation

Median Effective Flow Rate of High-Flow Nasal Oxygen During Painless Gastroscopy With Sedation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122468
Enrollment
Unknown
Registered
2026-04-14
Start date
2024-12-19
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications of painless gastroscopy

Interventions

Group A (18-30y):HFNO was administered at 30 L/min 1 minute before anesthesia. For each subsequent patient, the flow rate of HFNO was increased or decreased by 5 L/min based on whether the previous pa
Group B (31-40y):HFNO was administered at 30 L/min 1 minute before anesthesia. For each subsequent patient, the flow rate of HFNO was increased or decreased by 5 L/min based on whether the previous pa
Group C (41-50y):HFNO was administered at 30 L/min 1 minute before anesthesia. For each subsequent patient, the flow rate of HFNO was increased or decreased by 5 L/min based on whether the previous pa
Group D (51-60y):HFNO was administered at 30 L/min 1 minute before anesthesia. For each subsequent patient, the flow rate of HFNO was increased or decreased by 5 L/min based on whether the previous pa

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Age range: 18-60 years; 2.BMI: 18-25 kg/m^2; 3.ASA class I-II; 4.Mallampati class I-II without head/neck mobility impairment; 5.Voluntarily agree to participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of cardiovascular/cerebrovascular or pulmonary diseases; 2. Hepatic or renal insufficiency; 3. Obstructive sleep apnea syndrome (OSAS); 4. Acute upper gastrointestinal hemorrhage; 5. Pregnancy or lactation; 6. Hypersensitivity to anesthetic agents; 7. Current enrollment in other clinical trials.

Design outcomes

Primary

MeasureTime frame
The median effective oxygen flow and 95% confidence interval of HFNC in preventing hypoxemia;

Secondary

MeasureTime frame
Vital signs (perioperative blood pressure, heart rate, and respiratory rate (at 5 minutes before anesthesia induction (T0), 1 minute after anesthesia (T1), and 5 minutes after anesthesia (T2));Complications (respiratory desaturation (90% = SpO2= 94%);nausea or vomiting; nasal discomfort or bleeding);Total dose of propofol;Arterial blood gas partial pressures (PaCO2, PaO2, pH performed preoperatively, at the onset of hypoxemia, or postoperatively.);Gastroscopy operation time;Wake-up time;Intraoperative water irrigation volume;Patients' baseline characteristics (age, gender, height, weight, BMI, tracheal diameter);The operation time for gastroscopy;

Countries

China

Contacts

Public ContactCai Chengyi

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

cycai97@163.com+86 137 1050 5045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026